AXIONOVA develops research-use biological systems for practitioners, clinics, and qualified research entities. The platform connects verified compounds, structured protocol logic, governed delivery, and continuous physiology into one controlled operating model.
Thirty verified compounds across ten biological systems. Twenty-six SKUs in the active catalog. Every unit certified through ALETHRA, the AXIONOVA governance layer for identity, chain-of-custody, verification, authorization, and event records.
AXIONOVA uses two distinct intelligence layers. ALETHRA is the active governance layer behind identity, verification, authorization, protocol compliance, chain-of-custody, cartridge records, and device event logs across compounds, AXIS, SENSE, and partner access. ALETHA is the active AXIONOVA AI agent for coaching, protocol personalization, diet programming, guided education, practitioner support, and 24/7 user assistance. Governance and intelligence operate together. ALETHRA governs the system. ALETHA guides the experience.
Every AXIONOVA protocol begins with a defined research objective. The platform organizes compounds by biological system so practitioners can evaluate pathway fit, protocol structure, delivery requirements, and monitoring logic before any unit is released.
AXIONOVA organizes each unit inside a defined biological system. This structure gives practitioners a cleaner way to evaluate mechanism, pathway overlap, protocol window, companion compounds, and monitoring requirements.
The system model is built for disciplined review. It does not treat compounds as isolated products. It places every unit inside a pathway, a protocol logic, a verification record, and a controlled access framework.
Triple-agonist and visceral-fat pathway research for metabolic and appetite-regulation protocols.
Tissue integrity, inflammatory balance, angiogenesis, and connective-tissue remodeling research.
Cellular renewal, senescence research, telomere support, and long-range healthspan pathway design.
Endogenous growth-hormone signaling, pulsatile architecture, recovery support, and IGF-1 pathway research.
Every AXIONOVA compound is handled as a structured identity unit. Box, vial, lot, certificate, system classification, and digital record are aligned inside the ALETHRA governance framework.
ALETHRA certification applies to every unit. The certification layer supports identity review, purity documentation, batch traceability, chain-of-custody records, and partner-level access control.
AXIONOVA AXIS is the governed delivery instrument inside the AXIONOVA platform. It is a 28 mm OD by 165 mm hybrid smart-manual injector built around a reusable titanium and aluminum body, diamond knurling grip, keyed CDM cartridge seating, cartridge-level NFC verification, BLE 5.3 connectivity, and ALETHRA event governance.
AXIS does not hide the human action behind a black box. The user physically dials and delivers the dose. The electronics observe, verify, authorize, log, and govern the event. This architecture preserves direct manual control while adding identity verification, lock-state confirmation, protocol compliance checks, and device-level traceability.
AXIONOVA SENSE is a dual wearable system built around a titanium ring and a silicone bracelet with a titanium structural core. The ring functions as a compact vascular and sleep-capture node. The bracelet functions as the higher-capacity physiological hub for multi-sensor acquisition, motion context, impedance, and continuous body-state trends.
SENSE streams measured physiology into ALETHRA-governed provenance and AXIONOVA bio. ALETHA interprets baseline-aware wellness trends, protocol context, and practitioner review flags. Research Use Only intelligence is active. Regulated modules remain governed by validation and review.
The ring provides the finger-worn signal source for vascular, sleep, pulse, temperature, and motion context. The bracelet provides the higher-capacity hub for PPG, EDA, BioZ, four-terminal bioimpedance, thermal, and six-axis motion signals. Together, they create a dual-location wearable system under ALETHRA-governed analysis.
ALETHA connects SENSE Ring and Bracelet data with AXIS events, labs, symptoms, adherence records, and protocol timelines inside one governed Research Use Only intelligence loop.
ALETHA reads the measured SENSE stream before it interprets the result. PPG waveforms, pulse intervals, skin-temperature deltas, six-axis motion, BioZ magnitude and phase, EDA context, optional AS7058 ECG pathway data if implemented, signal confidence, and device telemetry are preserved as source-level evidence.
From that evidence, ALETHA derives baseline-aware intelligence: HRV trend, resting heart rate movement, sleep-stage probability, sleep continuity, nocturnal temperature deviation, SpO2 research-path trends when validated, hydration and fluid-shift context, activity strain, stress-load proxy, recovery readiness, and practitioner review flags.
The Knowledge Brain connects those outputs to the active protocol record. Recovery windows can be reviewed around TB-500 and BPC-157 repair research. Sleep architecture can be compared with DSIP or Ipamorelin GH-axis timing. Skin-temperature deviation can be interpreted beside GHK-Cu inflammation-adjacent context. BioZ body context can be trended against nutrition adherence. Every output remains Research Use Only and is designed to support governed review, not replace clinical judgment.
Recovery readiness, HRV trend, sleep-stage probability, temperature deviation, BioZ body context, adherence, and practitioner rules inform structured Research Use Only protocol recommendations.
SENSE windows are mapped around compound records to observe physiological context for repair, GH-axis, metabolic, immune, longevity, and peptide research protocols.
ALETHA separates measured signals from derived features, including PPG timing, SpO2 research trends, BioZ magnitude and phase, EDA, IMU artifact gating, temperature deltas, and signal confidence.
Ring and Bracelet data support sleep continuity, restlessness, nocturnal HRV, resting heart rate, temperature deviation, and baseline-aware recovery readiness.
BioZ body-context trend, activity load, HRV, temperature, nutrition adherence, CGM imports if present, and labs if provided help frame metabolic protocol context.
ALETHA flags repeated recovery strain, nocturnal oxygenation dip patterns, symptom clusters, protocol-window deviations, and low-confidence data for practitioner review.
AXIONOVA stacks align compatible compounds inside a defined biological objective. Each stack is organized by system, mechanism, sequencing, protocol window, monitoring requirements, delivery considerations, and practitioner review.
Stacks are designed for controlled research execution. They support disciplined intake, compound identity review, dose pathway planning, cartridge alignment where applicable, and ongoing event visibility through ALETHRA.
Designed for structured metabolic research involving appetite regulation, fat oxidation, and mitochondrial pathway support.
Three compounds. One coordinated protocol window with ALETHRA identity, chain-of-custody, authorization, and protocol event records.
AXIONOVA provides controlled access to verified compound units, AXIS governed delivery infrastructure, SENSE physiology streaming, CDM cartridge workflows, and system-based protocol logic for qualified partners.
Access is restricted to licensed practitioners, verified clinics, and qualified research entities. Partner review includes credential verification, institutional context, intended research use, chain-of-custody controls, and operational readiness. AXIONOVA does not sell directly to consumers.
AXIONOVA operates at the intersection of peptide science, small-molecule modulation, physiology sensing, and governed research infrastructure. The platform is built around defined systems, verified units, practitioner review, and traceable execution.
Each unit is classified by system, pathway, compound identity, dose format, lot record, documentation set, and access status. AXIS adds governed event records for delivery workflows. SENSE adds continuous physiology streams. ALETHRA connects the full framework through identity, authorization, and traceability.
Compound identity, documentation, lot records, and chain-of-custody are organized under ALETHRA certification across every unit in the catalog.
Each unit is mapped to one of ten biological systems with defined pathway context, protocol relevance, and structured review framework.
ALETHRA manages access, authorization, cartridge identity, device event logs, and protocol compliance records across compounds, AXIS, SENSE, and partner workflows.
AXIS contributes governed delivery events. SENSE contributes continuous physiology. Both feed structured practitioner review and platform intelligence.
AXIONOVA bio is the live mobile operating platform for the AXIONOVA system. It connects protocols, compounds, AXIS delivery events, SENSE physiology, ALETHRA verification records, ALETHA coaching, clinician oversight, lab data, progress tracking, and order history inside one controlled iOS and Android application.
The app is designed to make the full protocol cycle visible: what is active, what is scheduled, what has been completed, what requires attention, what the clinician sees, and what ALETHA recommends based on current data.
Personalized greeting, system status, active protocol card, today's compounds, today's actions, progress trends, system data, alerts, and learning content.
Adherence, weight, entered body-composition values, hydration logs, sleep, recovery, mood, injection count, manual logs, biomarkers, labs when provided, and SENSE trend data, paired with ALETHA pattern recognition and contextual alerts.
AXIS Integration Panel with cartridge identity, delivery event, calibration state, timestamp, adherence context, and review status. SENSE streams Ring HRV, sleep, temperature, motion, and SpO2 research trend support, plus Bracelet EDA and MAX30009 BioZ context when available, into the protocol record.
ALETHA AI video calls for protocol questions, diet programming, recovery support, and 24/7 assistance. Clinician sees the same dashboard with annotation capability for review and notes.
AXIONOVA is opening no-cost reservations for the next release of AXIS, SENSE Ring, and SENSE Bracelet. The reservation list is open to everyone. It does not require practitioner status, clinical access approval, or payment.
Reserve interest now and choose the device or devices you want to follow. AXIONOVA will use the list to prioritize release communication, availability updates, pre-order timing, and product-specific onboarding.
A position on the pre-order interest list for the AXIS hybrid smart-manual injection device.
A position on the pre-order interest list for the AXIONOVA SENSE titanium ring.
A position on the pre-order interest list for the AXIONOVA SENSE bracelet.
No payment is required to reserve. Reservation does not guarantee product availability, launch timing, or final eligibility for regulated workflows. AXIONOVA will contact reservation holders with product updates, availability windows, and access instructions.
AXIONOVA brings thirty verified compounds, ten biological systems, twenty-six active catalog SKUs, governed device infrastructure, and practitioner-only access into a single controlled platform.
For practitioners and qualified research entities, the next step is structured intake. Select the system, review the catalog, confirm eligibility, and request access through the clinical pathway.
